Newbridge Financial Services Group, Inc. Tg Therapeutics, Inc. Transaction History
Newbridge Financial Services Group, Inc.
- $262 Million
- Q2 2024
A detailed history of Newbridge Financial Services Group, Inc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 3,084 shares of TGTX stock, worth $82,959. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,084
Previous 3,662
15.78%
Holding current value
$82,959
Previous $55,000
1.82%
% of portfolio
0.02%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding TGTX
# of Institutions
304Shares Held
92.7MCall Options Held
1.9MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA13.7MShares$368 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$306 Million0.0% of portfolio
-
State Street Corp Boston, MA6.7MShares$180 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.65MShares$98.1 Million6.57% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.24MShares$87.2 Million0.07% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $3.91B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...